Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis
Dongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026
Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Blood Cancer Journal
|
June 18, 2024
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms
Amandeep Kaur, Alexandra E Rojek, Emily Symes, et al.
Blood Cancer Discovery
|
May 24, 2021
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA
Dongqing Yan, Anca Franzini, Anthony D Pomicter, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis
Dongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026
Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.
Blood Cancer Journal
|
June 18, 2024
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms
Amandeep Kaur, Alexandra E Rojek, Emily Symes, et al.
Blood Cancer Discovery
|
May 24, 2021
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA
Dongqing Yan, Anca Franzini, Anthony D Pomicter, et al.
Page
of 5